Corbus Pharmaceuticals (Nasdaq: CRBP) has bought global rights to more than 600 cannabinoid -based compounds from Jenrin Discovery. The jewel …
Corbus Pharmaceuticals (Nasdaq: CRBP) has bought global rights to more than 600 cannabinoid -based compounds from Jenrin Discovery. The jewel …